The Cost-efficiency and Care Effectiveness of Probiotic Administration with Antibiotics to Prevent Hospital-Acquired Clostridium difficile Infection
- 1 October 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Quality Management in Health Care
- Vol. 25 (4) , 238-243
Abstract
Health care facility–acquired Clostridium difficile infections (HCFA-CDI) have increased over the last several decades despite facilities developing protocols for prescribing probiotics with antibiotics to prevent HCFA-CDI. The literature does not consistently support this. A retrospective medical record review evaluated the care effectiveness of this practice. Care effectiveness was not found; patients receiving probiotics with antibiotics were twice as likely to develop HCFA-CDI (P = .004). Except with glycopeptides, patients were 1.88 times less likely to experience HCFA-CDI (P = .05).Keywords
This publication has 23 references indexed in Scilit:
- Burden of Clostridium difficile on the Healthcare SystemClinical Infectious Diseases, 2012
- Risk Factors for and Estimated Incidence of Community-associated Clostridium difficile Infection, North Carolina, USA 1Emerging Infectious Diseases, 2010
- Hospital-Associated Clostridium difficile Infection: Is It Necessary to Track Community-Onset Disease?Infection Control & Hospital Epidemiology, 2009
- Rising Economic Impact of Clostridium difficile-Associated Disease in Adult Hospitalized Patient PopulationInfection Control & Hospital Epidemiology, 2008
- Short- and Long-Term Attributable Costs of Clostridium difficile-Associated Disease in Nonsurgical InpatientsClinical Infectious Diseases, 2008
- A case-control study of community-associated Clostridium difficile infectionJournal of Antimicrobial Chemotherapy, 2008
- Case-Control Study of Antibiotic Use and Subsequent Clostridium difficile–Associated Diarrhea in Hospitalized PatientsInfection Control & Hospital Epidemiology, 2008
- Recommendations for Surveillance of Clostridium difficile–Associated DiseaseInfection Control & Hospital Epidemiology, 2007
- Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing ClostridiaNew England Journal of Medicine, 1978
- INTESTINAL FLORA IN NEW-BORN INFANTSA.M.A. American Journal of Diseases of Children, 1935